Brian Czerniecki

Remodeling the Immune Landscape in Breast Cancer Leptomeningeal Disease Using Dendritic Cell Therapy Is an Effective Treatment and Protects Against Disease Recurrence.

National Cancer Institute · R01

PI · $1.3M · h. Lee Moffitt Cancer Ctr & Res Inst

A HER-2/Neu Pulsed DC1 Vaccine for Patients with DCIS

National Cancer Institute · R01

Contact PI · $3.6M · University of Pennsylvania

General Clinical Research Center

National Center for Research Resources · M01

Project lead · $1.4K · University of Pennsylvania

HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer

Principal investigator · Completed · Phase 1

H. Lee Moffitt Cancer Center and Research Institute

A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS

Principal investigator · Withdrawn · Phase 1, Phase 2

H. Lee Moffitt Cancer Center and Research Institute

HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer Post Neoadjuvant Chemotherapy

Principal investigator · Completed · Phase 1

H. Lee Moffitt Cancer Center and Research Institute

DC Vaccine for Patients With Ductal Carcinoma In Situ

Principal investigator · Completed · Phase 1, Phase 2

Abramson Cancer Center at Penn Medicine